Lorenzo Arnaboldi
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 12
- Protease and Inhibitor Mechanisms 4
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 17
- Cholesterol and Lipid Metabolism 8
- Transplantation top 10%
-
- Plant biochemistry and biosynthesis 8
-
- Liver Disease Diagnosis and Treatment 4
-
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Alberto CorsiniRodolfo PaolettiStefano BellostaNicola FerriFranco BerniniR. FumagalliRobert E. PitasM. Canavesi
- Partner nations
- ItalyUnited StatesAustralia
In The Last Decade
Lorenzo Arnaboldi
39 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 93
- Endocrinology, Diabetes and Metabolism 327
- Cancer Research 268
- Surgery 755
- Transplantation 29
- Cardiology and Cardiovascular Medicine 239
Countries citing papers authored by Lorenzo Arnaboldi
This map shows the geographic impact of Lorenzo Arnaboldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Arnaboldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Arnaboldi more than expected).
Fields of papers citing papers by Lorenzo Arnaboldi
This network shows the impact of papers produced by Lorenzo Arnaboldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Arnaboldi. The network helps show where Lorenzo Arnaboldi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lorenzo Arnaboldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 16 | |
| 6 | 2020 | 14 | |
| 7 | 2017 | 2 | |
| 8 | 2017 | 21 | |
| 9 | 2015 | 44 | |
| 10 | 2013 | 7 | |
| 11 | 2013 | 11 | |
| 12 | 2011 | 44 | |
| 13 | 2010 | 30 | |
| 14 | 2010 | 20 | |
| 15 | 2009 | 47 | |
| 16 | 2008 | 51 | |
| 17 | 2007 | 6 | |
| 18 | 2006 | 219 | |
| 19 | 2001 | 16 | |
| 20 | 1997 | 83 |
About Lorenzo Arnaboldi
Lorenzo Arnaboldi is a scholar working on Cancer Research, Transplantation and Aging, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (12 papers), Plant biochemistry and biosynthesis (8 papers), Cholesterol and Lipid Metabolism (8 papers), Liver Disease Diagnosis and Treatment (4 papers), Protease and Inhibitor Mechanisms (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (327 citations), Cancer Research (268 citations) and Surgery (755 citations). Lorenzo Arnaboldi has collaborated with scholars based in Italy, United States and Australia. Frequent co-authors include Alberto Corsini, Rodolfo Paoletti, Stefano Bellosta, Nicola Ferri, Franco Bernini, R. Fumagalli, Robert E. Pitas, M. Canavesi, P. Quarato and Thomas M. Badger. Their work appears in journals such as PLoS ONE, Hepatology and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.